Agree, 2024 will be a monumental and epic year for Vivos and $RDGL. The recent BDD was a nice confirmation of FDA satisfaction with the IDE process taken by Vivos and data submitted to date and gives me even more confidence of IDE approval to move forward with clinical trials.